Metrics manifesting the strongest concurrent validity with providers identified from these records related to those who co-prescribed benzodiazepines (e.g., valium) and high levels of opioid analgesics (e.g., oxycodone), as well as those who wrote temporally overlapping prescriptions. The report concludes with a discussion of a variety of uses to which these metrics may be put, as well as problems and opportunities related to their use. (Publisher abstract modified)
Downloads
Similar Publications
- On the testing of Hardy-Weinberg proportions and equality of allele frequencies in males and females at biallelic genetic markers
- GC-MS and GC-IRD Studies on Dimethoxyamphetamines (DMA): Regioisomers Related to 2,5-DMA
- The Application of Amplicon Length Heterogeneity PCR (LH-PCR) for Monitoring the Dynamics of Soil Microbial Communities Associated With cadaver decomposition